Keros Therapeutics Inc. (KROS)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 66
-0.44
-3.964%
$
236.93M Market Cap
- P/E Ratio
- Div Yield
169,600 Volume
-5.27 Eps
$ 11.1
Previous Close 
Want to track KROS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Keros Therapeutics Inc. (KROS) Statistics
Valuation metrics
Market Cap 236.93M
Enterprise value -30.52M
Trailing P/E (ttm) -2.88
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 14.08
Price/Book (mrq) 0.8
Enterprise Value/Revenue -2.03
Enterprise Value/EBITDA 0.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 178.69K
Average volume (90 days) 189.85K
Price summary
52-Week low 9.69
52-Week high 22.55
Beta -
50-Day moving average 11.28
200-Day moving average 11.06
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.54%
Operating margin -6.76%
Operational effectiveness
Return on assets -0.29%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.76
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.2
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 21.96%
Book value per share (mrq) 13.25
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
